Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 66 entries
No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
ACVR2B
💬1. ACVR2B
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, TGF-beta signaling pathway, Signaling pathways regulating pluripotency of stem cells, Fluid shear stress and atherosclerosis 4件: Cytokine-cytokine receptor interaction, TGF-beta signaling pathway, Signaling pathways regulatin ... | Luspatercept
Luspatercept
💬1. ACVR2B
| Luspatercept | 1件: 60 60 💬1. ACVR2B
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 |
AR
💬2. AR
| 4件: Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer 4件: Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate canc ... | Nandrolone
Nandrolone
💬2. AR
| Nandrolone | 2件: 60 60, 85 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 |
AR
💬3. AR
| 4件: Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer 4件: Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate canc ... | Stanozolol
Stanozolol
💬3. AR
| Stanozolol | 1件: 60 60 💬3. AR
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 |
AR
💬4. AR
| 4件: Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer 4件: Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate canc ... | Nandrolone decanoate
Nandrolone decanoate
💬4. AR
| Nandrolone decanoate | 2件: 60 60, 85 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 |
AR
💬5. AR
| 4件: Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer 4件: Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate canc ... | Testosterone undecanoate
Testosterone undecanoate
💬5. AR
| Testosterone undecanoate | 2件: 13 13, 60 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 |
AR
💬6. AR
| 4件: Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer 4件: Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate canc ... | Testosterone
Testosterone
💬6. AR
| Testosterone | 8件: 1 1, 2, 3, 13, 60, 76, 78, 113 💬6. AR
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 |
AR
💬7. AR
| 4件: Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer 4件: Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate canc ... | Danazol
Danazol
💬7. AR
| Danazol | 5件: 60 60, 63, 64, 65, 285 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 |
BTK
💬8. BTK
| 7件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency 7件: NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor s ... | Ibrutinib
Ibrutinib
💬8. BTK
| Ibrutinib | 3件: 28 28, 60, 61 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 |
CASP9
💬9. CASP9
| 35件: Platinum drug resistance Platinum drug resistance, p53 signaling pathway, PI3K-Akt signaling pathway, Apoptosis, Apoptosis - multiple species, VEGF signaling pathway, Thyroid hormone signaling pathway, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Legionellosis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, Colorectal cancer, Pancreatic cancer, Endometrial cancer, Prostate cancer, Small cell lung cancer, Non-small cell lung cancer, Viral myocarditis, Lipid and atherosclerosis 35件: Platinum drug resistance, p53 signaling pathway, PI3K-Akt signaling pathway, Apoptosis, Apoptos ... | Rimiducid
Rimiducid
💬9. CASP9
| Rimiducid | 6件: 19 19, 60, 65, 284, 285, 326 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 |
CD52
💬10. CD52
| - | Alemtuzumab
Alemtuzumab
💬10. CD52
| Alemtuzumab | 22件: 13 13, 15, 19, 20, 36, 43, 44, 46, 49, 51, 60, 62, 63, 65, 85, 96, 164, 234, 283, 284, 285, 326 💬10. CD52
|